Showing 1 - 20 results of 51 for search 'Vladimir Tolmachev', query time: 0.03s
Refine Results
-
1
Affibody Molecules as Targeting Vectors for PET Imaging by Vladimir Tolmachev, Anna Orlova
Published 2020-03-01
Article -
2
Radionuclides in Diagnostics and Therapy of Malignant Tumors: New Development by Vladimir Tolmachev, Anzhelika Vorobyeva
Published 2022-01-01
Article -
3
PET and SPECT Imaging of the EGFR Family (RTK Class I) in Oncology by Sara S. Rinne, Anna Orlova, Vladimir Tolmachev
Published 2021-04-01
Article -
4
-
5
177Lu-labeled PSMA targeting therapeutic with optimized linker for treatment of disseminated prostate cancer; evaluation of biodistribution and dosimetry by Ayman Abouzayed, Kamila Seitova, Kamila Seitova, Fanny Lundmark, Vitalina Bodenko, Vitalina Bodenko, Maryam Oroujeni, Maryam Oroujeni, Vladimir Tolmachev, Vladimir Tolmachev, Ulrika Rosenström, Anna Orlova, Anna Orlova
Published 2023-09-01
Article -
6
Two Novel [68Ga]Ga-Labeled Radiotracers Based on Metabolically Stable [Sar11]RM26 Antagonistic Peptide for Diagnostic Positron Emission Tomography Imaging of GRPR-Positive Prostate... by Panagiotis Kanellopoulos, Ekaterina Bezverkhniaia, Ayman Abouzayed, Ulrika Rosenström, Vladimir Tolmachev, Anna Orlova
Published 2024-04-01
Article -
7
-
8
Drug Conjugates Based on a Monovalent Affibody Targeting Vector Can Efficiently Eradicate HER2 Positive Human Tumors in an Experimental Mouse Model by Tianqi Xu, Haozhong Ding, Anzhelika Vorobyeva, Maryam Oroujeni, Anna Orlova, Vladimir Tolmachev, Torbjörn Gräslund
Published 2020-12-01
Article -
9
-
10
-
11
-
12
-
13
-
14
Position for Site-Specific Attachment of a DOTA Chelator to Synthetic Affibody Molecules Has a Different Influence on the Targeting Properties of Ga-Compared to In-Labeled Conjugat... by Hadis Honarvar, Joanna Strand, Anna Perols, Anna Orlova, Ram Kumar Selvaraju, Amelie Eriksson Karlström, Vladimir Tolmachev
Published 2014-12-01
Article -
15
Direct Intra-Patient Comparison of Scaffold Protein-Based Tracers, [<sup>99m</sup>Tc]Tc-ADAPT6 and [<sup>99m</sup>Tc]Tc-(HE)<sub>3</sub>-G3, for Imaging of HER2-Positive Breast Can... by Olga Bragina, Vladimir Chernov, Alexey Schulga, Elena Konovalova, Sophia Hober, Sergey Deyev, Jens Sörensen, Vladimir Tolmachev
Published 2023-06-01
Article -
16
Radionuclide Therapy of HER2-Expressing Xenografts Using [<sup>177</sup>Lu]Lu-ABY-027 Affibody Molecule Alone and in Combination with Trastuzumab by Yongsheng Liu, Tianqi Xu, Anzhelika Vorobyeva, Annika Loftenius, Vitalina Bodenko, Anna Orlova, Fredrik Y. Frejd, Vladimir Tolmachev
Published 2023-04-01
Article -
17
HER3 PET Imaging: <sup>68</sup>Ga-Labeled Affibody Molecules Provide Superior HER3 Contrast to <sup>89</sup>Zr-Labeled Antibody and Antibody-Fragment-Based Tracers by Sara S. Rinne, Charles Dahlsson Leitao, Ayman Abouzayed, Anzhelika Vorobyeva, Vladimir Tolmachev, Stefan Ståhl, John Löfblom, Anna Orlova
Published 2021-09-01
Article -
18
Preclinical evaluation of new GRPR-antagonists with improved metabolic stability for radiotheranostic use in oncology by Panagiotis Kanellopoulos, Adam Mattsson, Ayman Abouzayed, Karim Obeid, Berthold A. Nock, Vladimir Tolmachev, Theodosia Maina, Anna Orlova
Published 2024-02-01
Article -
19
The GRPR Antagonist [<sup>99m</sup>Tc]Tc-maSSS-PEG<sub>2</sub>-RM26 towards Phase I Clinical Trial: Kit Preparation, Characterization and Toxicity by Ayman Abouzayed, Jesper Borin, Fanny Lundmark, Anastasiya Rybina, Sophia Hober, Roman Zelchan, Vladimir Tolmachev, Vladimir Chernov, Anna Orlova
Published 2023-05-01
Article -
20
Heterodimeric Radiotracer Targeting PSMA and GRPR for Imaging of Prostate Cancer—Optimization of the Affinity towards PSMA by Linker Modification in Murine Model by Fanny Lundmark, Ayman Abouzayed, Bogdan Mitran, Sara S. Rinne, Zohreh Varasteh, Mats Larhed, Vladimir Tolmachev, Ulrika Rosenström, Anna Orlova
Published 2020-07-01
Article